Drug intelligence / Profile preview

pentadecanoic acid

Development stage
Preclinical
Lead developer
Seraphina Therapeutics
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Pentadecanoic acid (C15:0) is an essential odd-chain saturated fatty acid recognized for its broad health benefits and pleiotropic mechanisms of action. It acts as a dual partial agonist of peroxisome proliferator-activated receptor α/δ (PPAR-α/δ), an activator of AMP-activated protein kinase (AMPK), and an inhibitor of mammalian target of rapamycin (mTOR), Janus kinase-signal transducer and activator of transcription pathway (JAK-STAT), and histone deacetylase 6 (HDAC6)[1][3][5]. These actions are associated with anti-inflammatory, antifibrotic, anticancer, metabolic-regulating, mitochondrial-repairing, membrane-stabilizing, antimicrobial properties[1][3]. Epidemiological studies link higher circulating levels to reduced risk for cardiometabolic diseases and improved liver function[1][5]. C15:0 is being developed primarily as a dietary supplement to support healthy aging and longevity by targeting cellular processes involved in aging such as inflammation control, mitochondrial function restoration, membrane stability enhancement, glucose metabolism regulation, cholesterol lowering, immune modulation and gut microbiome improvement[1][2][4][6].

Brand names
Fatty15Fatty-15Fatty 15
Other names
pentadecanoic acidC15:015:0n-pentadecanoic acid
02

Targets

PPARD (Peroxisome proliferator–activated receptor delta)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on pentadecanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pentadecanoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call